TD2 Oncology

TD2 is built specifically for oncology development, supporting programs from preclinical proof of concept and biomarker strategy through IND preparation and clinical trial delivery. Its capabilities include disease models, PK/PD, flow cytometry, regulatory affairs, protocol design, site networks, project management and data services. TD2 also highlights experience with radiopharmaceuticals, antibody-drug conjugates, cell and gene therapies and cancer vaccines.